TECHTRONIC IND(00669)

Search documents
大行评级|花旗:上调创科实业目标价至125港元 重申“买入”评级

Ge Long Hui· 2025-08-06 02:21
花旗发表报告指,创科实业上半年业绩创历史新高,营业额增长7.1%,纯利增长14.2%,略低于该行预 测的17%。尽管如此,公司表示有信心在今年实现中至高单位数的收入增长,以及将EBIT利润率由去 年的8.7%扩大至10%的中期目标。 该行微调创科实业2025至2027年的盈利预测,目标价由110港元上调至125港元,重申"买入"评级;预期 自2026年起,由于更快赢得市场份额及行业增长正常化,收入将加速以高单位数增长。 ...
港股公告掘金 | 中国铁塔上半年股东应占利润57.57亿元 同比增长8.0%





Zhi Tong Cai Jing· 2025-08-05 15:30
Major Events - Shiyao Group's (01093) application for the listing of Semaglutide injection has been accepted by the National Medical Products Administration (NMPA) [1] - Gilead Sciences-B (01672) has completed the enrollment of overweight or obese subjects in the Phase IIa study of the small molecule oral GLP-1R agonist ASC30 in the United States [1] - China Biopharmaceutical (01177) has received NMPA approval for the clinical trial application of TQC3302 "ICS/LAMA/LABA soft mist inhalation preparation" [1] - Jiaogepeng Holdings (01450) plans to acquire 100% equity of Hangzhou Jiaogepeng Education Technology Co., Ltd. for 180 million yuan [1] Financial Data - China Tower (00788) reported a mid-term profit attributable to shareholders of 5.757 billion yuan, an increase of 8.0% year-on-year, with the revenue share from its two wings business exceeding 14% [1] - Techtronic Industries (00669) reported a mid-term profit attributable to shareholders of 628 million USD, an increase of 14.17% year-on-year, with a dividend of 1.25 HKD per share [1] - Yum China (09987) reported a second-quarter operating profit of 304 million USD, a year-on-year increase of 14% [1] - Zibuyu (02420) issued a profit warning, expecting mid-term revenue to increase by approximately 30%-40% to between 1.9 billion and 2.047 billion yuan [1] - Angelalign (06699) issued a profit warning, expecting net profit for the first half of the year to be approximately 13.4 million to 14.8 million USD, a year-on-year increase of approximately 538.1% to 604.8% [1] - Boya Interactive (00434) issued a profit warning, expecting mid-term profit attributable to shareholders to decrease by approximately 25% to 35% [1] - Zhenjiu Lidu (06979) issued a profit warning, expecting mid-term net profit attributable to shareholders to decline by 23% to 24% [1] - Fourth Paradigm (06682) expects a narrowed adjusted net loss for the mid-term, down 68% to 73% year-on-year [1]


创科实业中期营收约78亿美元 百胜中国二季度经营利润同比增逾一成
Xin Lang Cai Jing· 2025-08-05 12:18
Performance Summary - Techtronic Industries (00669.HK) reported a revenue of $7.8 billion for the first half of the year, an increase of 7.5% year-on-year, with a net profit of $628 million, up 14.2% [1] - Yum China (09987.HK) achieved revenue of $2.8 billion in Q2 2025, a 4% increase year-on-year, with an operating profit of $304 million, up 14% [1] - Shiseido (02145.HK) expects mid-term revenue of approximately ¥4.09-4.11 billion, a year-on-year increase of about 16.8%-17.3%, and a net profit of approximately ¥540-560 million, up about 30.9%-35.8% [1] - Prosperity Industrial Trust (00778.HK) reported revenue of approximately HK$854 million for the first half, a decrease of about 2% year-on-year, while distributable income to unitholders increased by 2.06% to HK$377 million [1] - Zibuyu (02420.HK) anticipates mid-term revenue of approximately RMB 1.9-2.047 billion, a year-on-year increase of about 30%-40%, with a net profit of approximately RMB 100-110 million, up about 10%-20% [1] - Angelalign Technology (06699.HK) expects mid-term net profit of approximately $13.4-14.8 million, a year-on-year increase of approximately 538.1%-604.8% [1] Company News - Sunac China (01918.HK) reported a cumulative contract sales amount of ¥25.08 billion for the first seven months of 2025, a decrease of 9.43% year-on-year, with July contract sales of approximately ¥1.53 billion, an increase of 8.51% [3] - Xingye Holdings (00132.HK) entered into a financing lease agreement with Heilongjiang Mudanjiang Agricultural Reclamation Xinneng Thermal Power, involving an investment of ¥100 million [3] - China Biopharmaceutical (01177.HK) received NMPA approval for the clinical trial application of TQC3302, an ICS/LAMA/LABA soft mist inhalation formulation for the maintenance treatment of chronic obstructive pulmonary disease [3] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.05 million shares at a cost of about HK$105 million, with buyback prices ranging from HK$95.35 to HK$96.3 [3] - Hang Seng Bank (00011.HK) repurchased 200,000 shares at a cost of approximately HK$22.717 million, with buyback prices between HK$113.1 and HK$114.2 [4]
创科实业将于9月19日派发中期股息每股1.25港元

Zhi Tong Cai Jing· 2025-08-05 11:18
创科实业(00669)公布,将于2025年9月19日派发中期股息每股1.25港元。 ...
创科实业(00669)将于9月19日派发中期股息每股1.25港元

智通财经网· 2025-08-05 11:18
智通财经APP讯,创科实业(00669)公布,将于2025年9月19日派发中期股息每股1.25港元。 ...
创科实业(00669) - 截至2025年6月30日止六个月的中期股息及暂停办理股份过户登记手续

2025-08-05 11:10
Philip Roberts先生、吳家暉女士及黃子全先生。 免責聲明 第 2 頁 共 2 頁 v 1.1.1 EF001 | 其他信息 | | --- | | 其他信息 不適用 | | 發行人董事 | | 董事會包括︰六名集團執行董事,即主席Horst Julius Pudwill先生、副主席Stephan Horst Pudwill先生、行政總裁Steven Philip Richman先生、陳建華先生、陳志聰先生及Camille Jojo先生;及八名獨立非執行董事,即Peter David Sullivan先生、Johannes | | Gerhard Hesse先生、Robert Hinman Getz 先生、Virginia Davis Wilmerding女士、Caroline Christina Kracht女士、Andrew | EF001 | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因 | | --- | --- | | | 股票 ...
创科实业发布中期业绩 股东应占溢利6.28亿美元 同比增加14.17%
Zhi Tong Cai Jing· 2025-08-05 11:06
Core Viewpoint - The company reported record sales for the first half of 2025, with a revenue of $7.833 billion, reflecting a year-on-year increase of 7.13% and a net profit attributable to shareholders of $628 million, up 14.17% year-on-year [1] Financial Performance - Revenue for the first half of 2025 reached $7.833 billion, representing a 7.13% increase compared to the previous year [1] - Net profit attributable to shareholders was $628 million, marking a 14.17% year-on-year growth [1] - Basic earnings per share were 34.37 cents [1] - The company proposed an interim dividend of 125 Hong Kong cents per share [1] Brand Performance - The company's leading brands, MILWAUKEE and RYOBI, showed exceptional performance, with MILWAUKEE's business growing by 11.9% and RYOBI by 8.7% in local currency [1] - Overall sales growth in local currency was 7.5%, while in reported currency it was 7.1% [1] Strategic Focus - The company strategically reduced sales in non-core businesses compared to the first half of 2024, focusing on executing business plans to streamline product offerings and enhance profitability in these areas [1]
创科实业(00669)发布中期业绩 股东应占溢利6.28亿美元 同比增加14.17%
智通财经网· 2025-08-05 11:03
Core Viewpoint - The company reported record sales for the first half of 2025, with a revenue of $7.833 billion, reflecting a year-on-year increase of 7.13% and a net profit attributable to shareholders of $628 million, up 14.17% year-on-year [1] Financial Performance - Revenue for the six-month period ending June 30, 2025, was $7.833 billion, representing a 7.13% increase compared to the previous year [1] - Net profit attributable to shareholders was $628 million, which is a 14.17% increase year-on-year [1] - Basic earnings per share were 34.37 cents [1] - The company proposed an interim dividend of 1.25 Hong Kong dollars per share [1] Brand Performance - The company's leading brands, MILWAUKEE and RYOBI, showed exceptional performance, with MILWAUKEE's business growing by 11.9% and RYOBI by 8.7% in local currency [1] - Overall sales growth in local currency was 7.5%, while in reported currency it was 7.1% [1] Strategic Focus - The company strategically reduced sales in non-core businesses compared to the first half of 2024, focusing on executing business plans to streamline product offerings and enhance profitability in these areas [1]
创科实业(00669.HK)中期纯利增长14.2%至6.28亿美元
Ge Long Hui· 2025-08-05 10:59
Core Viewpoint - The company reported strong performance for the first half of the year, with significant increases in both sales and net profit, indicating robust growth and operational efficiency [1] Financial Performance - Sales increased by 7.5% to $7.8 billion, while net profit rose by 14.2% to $628 million [1] - The company declared an interim dividend of HKD 1.25 per share (approximately USD 0.1609), compared to HKD 1.08 per share (approximately USD 0.1390) in 2024 [1] Brand Performance - The flagship brand MILWAUKEE saw sales growth of 11.9%, maintaining its position as the leading professional power tool brand globally [1] - The consumer brand RYOBI, known for rechargeable tools and outdoor electric tools, experienced an 8.7% increase in sales [1] Cash Flow and Financial Position - Free cash flow for the first half of 2025 reached $468 million, with the company ending the period in a net cash position [1]
创科实业(00669) - 2025 - 中期业绩

2025-08-05 10:52
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責,對其準確性或完整性亦 不發表任何聲明,並明確表示,概不對因本公佈全部或任何部份內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 TECHTRONIC INDUSTRIES COMPANY LIMITED 創 科 實 業 有 限 公 司 (於香港註冊成立之有限公司) (股份代號:669) • 創科實業上半年表現強勁,按當地貨幣計算,銷售額增長 7.5%至 78 億美元,純利增長 14.2%至 6.28 億美元。 • 按當地貨幣計算,我們的旗艦品牌MILWAUKEE業務銷售額增長11.9 %,延續全球第一專業電動 工具品牌的主導領導地位。 • 全球首屈一指的消費者充電式工具及戶外電動工具品牌 RYOBI,按當地貨幣計算,銷售額增長 8.7%。 • 於二零二五年上半年,創科實業的自由現金流達到4.68億美元,期末處於淨現金狀況。 於二零二五年上半年,創科實業錄得破紀錄的 7,800,000,000 美元銷售額,按當地貨幣計算增長 7.5%, 按列賬貨幣計算則增長 7.1%。期內,MILWAUKEE 及 RYOBI 兩大領先品牌均表現非 ...